Phase I trial of intratumoral pIL-12 [gene therapy] electroporation in malignant melanoma
Phase of Trial: Phase I
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Tavokinogene telsaplasmid (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 19 Apr 2016 Results of retrospective analysis of long-term, follow-up data published in an OncoSec media release.
- 19 Apr 2016 Results of retrospective analysis of long-term, follow-up data were presented at the the American Association of Cancer Research (AACR) Annual Meeting 2016, according to an OncoSec Medical media release.